[(177)Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies.

Gustafsson A, Svedberg H, Rinne SS, Bertilsson F, Selvaraju RK, Lundgren Mortensen AC, Lindskog C, Nestor M

DOI: 10.2967/jnumed.125.271705
Published: 2026 Sep 2
Container: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2967/jnumed.125.271705,
  title = {[(177)Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies.},
  author = {Gustafsson A and Svedberg H and Rinne SS and Bertilsson F and Selvaraju RK and Lundgren Mortensen AC and Lindskog C and Nestor M},
  year = {2026},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  doi = {10.2967/jnumed.125.271705},
  url = {https://doi.org/10.2967/jnumed.125.271705}
}

RIS

TY  - JOUR
TI  - [(177)Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies.
AU  - Gustafsson A
AU  - Svedberg H
AU  - Rinne SS
AU  - Bertilsson F
AU  - Selvaraju RK
AU  - Lundgren Mortensen AC
AU  - Lindskog C
AU  - Nestor M
PY  - 2026
JO  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
DO  - 10.2967/jnumed.125.271705
UR  - https://doi.org/10.2967/jnumed.125.271705
ER  -

APA

A, G., H, S., SS, R., F, B., RK, S., AC, L. M., C, L., & M, N. (2026). [(177)Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.271705

Source records

pubmed · retrieved 2026-09-25T23:46:25.249Z